Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10213274 | International Journal of Cardiology | 2018 | 4 Pages |
Abstract
Combination analyses of functional gut metabolic pathways and metabolomics data in this small pilot study suggest that BHBP may have greater oxidative stress markers in plasma, greater inflammatory potential of the gut microbiome and altered metabolites with gut microbial functions implying insulin resistance. A fuller understanding of these potential differences could lead to race-based treatments for hypertension.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jacquelyn M. Walejko, Seungbum Kim, Ruby Goel, Eileen M. Handberg, Elaine M. Richards, Carl J. Pepine, Mohan K. Raizada,